In normal cells, active phosphatase and tensin homolog (PTEN) inhibits PI3K/Akt activation, whereas many types of cancers are PTEN-deficient, leading to aberrant PI3K/Akt signalling [249,259]. The gene discussed is PTEN; the disease is cancer.